Kotbi Nabil, Han Bernadine, Cheng Duncan, Odom Anna E
Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
Int Med Case Rep J. 2015 Apr 29;8:97-8. doi: 10.2147/IMCRJ.S65655. eCollection 2015.
We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.